CNBX PHARMACEUTICALS INC. — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/16b69532-bf0d-444a-af91-602103769f17/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2024-09-01 – 2025-08-31 | evidence 0001683168-25-008736 |
| FY 2024 | $130.1k | 2023-09-01 – 2024-08-31 | evidence 0001683168-24-008433 |
| FY 2023 | $410.2k | 2022-09-01 – 2023-08-31 | evidence 0001683168-23-008557 |
| FY 2022 | $30.0k | 2021-09-01 – 2022-08-31 | evidence 0001683168-23-008557 |
| FY 2021 | $0 | 2020-09-01 – 2021-08-31 | evidence 0001683168-21-006005 |
| FY 2020 | $7.2k | 2019-09-01 – 2020-08-31 | evidence 0001683168-20-003686 |
| FY 2019 | $9.8k | 2018-09-01 – 2019-08-31 | evidence 0001683168-19-003852 |
| FY 2018 | $9.6k | 2017-09-01 – 2018-08-31 | evidence 0001683168-18-003584 |
| FY 2017 | $5.7k | 2016-09-01 – 2017-08-31 | evidence 0001683168-17-003260 |
| FY 2016 | $112.5k | 2015-09-01 – 2016-08-31 | evidence 0001683168-16-000925 |
| FY 2015 | $0 | 2014-09-01 – 2015-08-31 | evidence 0001683168-16-000925 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CNBX PHARMACEUTICALS INC. — all facts · Net Income · Operating Income